Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (866) Campral (acamprosate calcium), Forest Laboratories,
...Newly Approved Drug Therapies (866) Campral (acamprosate calcium), Forest Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Campral (acamprosate calcium) Company: Forest Laboratories Approval Status: Approved August, 2004 Treatment Area: Alcohol dependence General Information ...
View Page

2.  Study Posting (799) Trial #156616, Substance Abuse, Boston, MA
...Trial #156616, Substance Abuse, Boston, MA Trial Information A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse ...
...Google Map support@centerwatch.com syoun@partners.org A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse ...
View Page

3.  Study Posting (799) Trial #156614, Alcohol Dependence, Boston, MA
...Trial #156614, Alcohol Dependence, Boston, MA Trial Information A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse ...
...Google Map support@centerwatch.com syoun@partners.org A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse ...
View Page

4.  Study Posting (799) Trial #156615, Depression (Major/Severe), Boston, MA
...156615, Depression (Major/Severe), Boston, MA Trial Information A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse ...
...Google Map support@centerwatch.com syoun@partners.org A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse ...
View Page

5.  CenterWatch: Pharmacology/Toxicology Approved Drug Therapies
...treatment of chemotherapy-induced nausea and vomiting, Approved September 2008 Drugs Approved in 2004 Campral (acamprosate calcium) ; Forest Laboratories; For the treatment of alcohol dependence and the maintenance of alcohol abstinence ...
View Page

6.  Study Posting (4971) Trial #161600, Alcohol Dependence, Maitland, FL
...within the past year) on any drugs • The following medications are prohibited during this study: acamprosate, all anxiolytics, all antidepressants, baclofen, benzodiazepines, buprenorphine, carbamazepine, disulfiram, divalproex sodium, ethosuximide, felbamate, gabapentin, lamotrigine ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (9), Alcohol Dependence
...in the study. July 15, 2002 The FDA has issued a non-approvable letter for acamprosate , a medication designed to help maintain abstinence in patients with alcohol dependence. After completing its ...
...pharmacokinetic analyses and pre-clinical studies. Lipha S.A. , a subsidiary of Merck KGaA, developed acamprosate and licensed the US marketing and distribution rights to Forest Laboratories . Jobson Medical Information • Privacy ...
View Page

8.  CenterWatch: List of Newly Approved Drug Thearapies
...For the treatment of wet age-related macular degeneration., Approved December 2004 Pharmacology/Toxicology Campral (acamprosate calcium) ; Forest Laboratories; For the treatment of alcohol dependence and the maintenance of alcohol abstinence ...
View Page